
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $99M | -- | -- | $0.03 | -- |
08/06/2025 | Q2 | $101M | -- | -- | $0.29 | -- |
05/06/2025 | Q1 | $193M | $170.8M | $1.69 | $1.75 | -$0.06 |
02/10/2025 | Q4 | $173.5M | $127.5M | $0.96 | $0.95 | $0.01 |
11/04/2024 | Q3 | $116M | $92.9M | -- | $0.08 | -- |
08/06/2024 | Q2 | $94M | $95.7M | $0.27 | $0.29 | -$0.02 |
05/07/2024 | Q1 | $209M | $178.7M | $1.69 | $1.59 | $0.10 |
02/13/2024 | Q4 | $156.3M | $129.6M | $0.97 | $0.94 | $0.03 |
11/07/2023 | Q3 | -- | -- | $0.09 | $0.05 | $0.04 |
08/01/2023 | Q2 | -- | -- | $0.25 | $0.29 | -$0.04 |
05/02/2023 | Q1 | -- | -- | $1.51 | $1.46 | $0.05 |
02/14/2023 | Q4 | -- | -- | $0.91 | $0.84 | $0.07 |
11/01/2022 | Q3 | -- | -- | $0.03 | $0.01 | $0.03 |
08/02/2022 | Q2 | -- | -- | $0.30 | $0.25 | $0.05 |
05/03/2022 | Q1 | -- | -- | $1.35 | $1.31 | $0.04 |
02/01/2022 | Q4 | -- | -- | $0.93 | $1.04 | -$0.11 |
11/02/2021 | Q3 | -- | -- | -- | $0.03 | -- |
08/03/2021 | Q2 | -- | -- | $0.18 | $0.20 | -$0.02 |
05/04/2021 | Q1 | -- | -- | $1.26 | $1.15 | $0.11 |
02/02/2021 | Q4 | -- | -- | $0.90 | $0.84 | $0.06 |
10/29/2020 | Q3 | -- | -- | $0.02 | -- | -- |
07/30/2020 | Q2 | -- | -- | $0.21 | $0.22 | -$0.01 |
04/30/2020 | Q1 | -- | -- | $1.02 | $1.16 | -$0.14 |
01/30/2020 | Q4 | -- | -- | $0.77 | $0.78 | -$0.01 |
10/24/2019 | Q3 | -- | -- | $0.15 | $0.14 | $0.01 |
07/25/2019 | Q2 | -- | -- | $0.27 | $0.21 | $0.07 |
04/25/2019 | Q1 | -- | -- | $1.78 | $1.25 | $0.53 |
01/31/2019 | Q4 | -- | -- | $0.74 | $0.69 | $0.05 |
10/25/2018 | Q3 | -- | -- | $0.19 | $0.07 | $0.12 |
07/26/2018 | Q2 | -- | -- | $0.24 | -- | -- |
04/26/2018 | Q1 | -- | -- | $1.06 | -- | -- |
02/01/2018 | Q4 | -- | -- | $0.76 | -- | -- |
10/26/2017 | Q3 | -- | -- | $0.16 | -- | -- |
07/27/2017 | Q2 | -- | -- | $0.23 | -- | -- |
04/27/2017 | Q1 | -- | -- | $0.88 | -- | -- |
02/02/2017 | Q4 | -- | -- | $0.73 | -- | -- |
10/20/2016 | Q3 | -- | -- | $0.25 | -- | -- |
07/21/2016 | Q2 | -- | -- | $0.18 | -- | -- |
04/21/2016 | Q1 | -- | -- | $0.78 | -- | -- |
01/28/2016 | Q4 | -- | -- | $0.67 | -- | -- |
10/22/2015 | Q3 | -- | -- | $0.12 | -- | -- |
Unitil reported $170.8M worth of top line sales in its most recent quarter.
Unitil announced earnings per share of $1.69 which represents a miss of analyst forecast a $1.75 per share.
Unitil reported $75.8M that represents $4.68 per share over the last quarter.
Unitil's earnings are forecast to grow from $2.92 per share to $2.91 per share next year representing an increase of 5.34%.
Unitil's next earnings date is August 6, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.